1. Bostan, M, Ataman, M, Bostan, IS, et al. Targets and assay types for COVID-19 diagnosis. J Immunoassay Immunochem 2020; 41: 946–959.
Google Scholar | Crossref | Medline2. Oved, K, Olmer, L, Shemer-Avni, Y, et al. Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation. Eclinical Med 2020; 29: 100651.
Google Scholar | Crossref | Medline3. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of week 9 , updated 11 March 2021, www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases/ (accessed 14 March 2021).
Google Scholar4. National SARS-CoV-2 Serology Assay Evaluation Group . Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. Lancet Infect Dis 2020; 20: 1390–1400.
Google Scholar | Crossref | Medline5. Petherick, A. Developing antibody tests for SARS-CoV-2. Lancet 2020; 395: 1101–1102.
Google Scholar | Crossref | Medline6. Harritshøj, LH, Gybel-Brask, M, Afzal, S, et al. Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories. J Clin Microbiol 2021; 59: 02596–02520.
Google Scholar | Crossref | Medline7. Kittel, M, Findeisen, P, Muth, MC, et al. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® Anti-SARS-CoV-2 immunoassay. Int J Infect Dis 2021; 105: 632–638.
Google Scholar8. Wakita, M, Idei, M, Saito, K, et al. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. PLoS One 2021; 16: e0246536.
Google Scholar | Crossref | Medline9. Irsara, C, Egger, AE, Prokop, W, et al. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay. Clin Chem Lab Med 2021; 59: 1143–1154.
Google Scholar10. Instituto de Salud Carlos III . Estrategia de detección precoz, vigilancia y control de COVID-19. Actualizado a 26 de febrero de 2021, www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf (accessed 14 March 2021).
Google Scholar11. Área de Calidad de la Subdirección General de Promoción, Prevención y Calidad Centro de Coordinación de Alertas y Emergencias Sanitarias Dirección General de Salud Pública . Ministerio de Sanidad. Recomendaciones para la programación de cirugía en condiciones de seguridad durante la pandemia COVID-19, www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Cirugia_electiva.pdf (accessed 14 March 2021).
Google Scholar12. Jung, J, Garnett, E, Jariwala, P, et al. Clinical performance of a semi-quantitative assay for SARS-CoV2 IgG and SARS-CoV2 IgM antibodies. Clin Chim Acta 2020; 510: 790–795.
Google Scholar | Crossref | Medline13. Agència de Salut Pública de Catalunya. Annex al “Procediment d'actuació enfront de casos d’infecció pel nou coronavirus SARS-CoV-2” (18.10.20) en fase de mitigació (30.10.20). https://canalsalut.gencat.cat/web/.content/_A-Z/C/coronavirus-2019-ncov/material-divulgatiu/protocol-fase-mitigacio.pdf (2020, accessed 14 March 2021).
Google Scholar14. Perkmann, T, Perkmann-Nagele, N, Breyer, MK, et al. Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity. Clin Chem 2020; 66: 1405–1413.
Google Scholar | Crossref | Medline15. Favresse, J, Eucher, C, Elsen, M, et al. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies. Clin Chem 2020; 66: 1104–1106.
Google Scholar | Crossref | Medline16. Tre-Hardy, M, Wilmet, A, Beukinga, I, et al. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med 2020; 8: 1357–1364.
Google Scholar | Crossref17. Plebani, M, Padoan, A, Negrini, D, et al. Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? Clin Chim Acta 2020; 509: 1–7.
Google Scholar | Crossref | Medline18. Egger, M, Bundschuh, C, Wiesinger, K, et al. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma. Clin Chim Acta 2020; 509: 18–21.
Google Scholar | Crossref | Medline19. Turbett, SE, Anahtar, M, Dighe, AS, et al. Evaluation of three commercial SARS-CoV-2 serologic assays and their performance in two-test algorithms. J Clin Microbiol 2020; 59: 20. e01892-
Google Scholar | Crossref20. Perkmann, T, Perkmann-Nagele, N, Oszvar-Kozma, M, et al. Increasing both specificity and sensitivity of SARS-CoV-2 antibody tests by using an adaptive orthogonal testing approach. MedRxiv. 2020. https://doi.org/10.1101/2020.11.05.20226449.
Google Scholar21. Ripperger, TJ, Uhrlaub, JL, Watanabe, M, et al. Orthogonal SARS-CoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity. Immunity 2020; 53: 925–933.e4.
Google Scholar | Crossref | Medline22. Burbelo, PD, Riedo, FX, Morishima, C, et al. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J Infect Dis 2020; 222: 206–213.
Google Scholar | Crossref | Medline23. Li, D, Li, J. Immunologic testing for SARS-CoV-2 infection from the antigen perspective. J Clin Microbiol 2021; 59: e02160–20.
Google Scholar24. Padoan, A, Bonfante, F, Sciacovelli, L, et al. Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer. Clin Chem Lab Med 2020; 58: e247–e249.
Google Scholar | Crossref | Medline25. Emmenegger, M, De Cecco, E, Lamparter, D, et al. Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region. MedRxiv. 2020. https://doi.org/10.1101/2020.05.31.20118554.
Google Scholar26. L, Bert, N, Clapham, HE, Tan, AT, et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J Exp Med 2021; 218: e20202617.
Google Scholar | Crossref | Medline27. Melenotte, C, Silvin, A, Goubet, AG, et al. Immune responses during COVID-19 infection. Oncoimmunology 2020; 9: 1807836.
Google Scholar | Crossref | Medline